Home

The Department of Biomedicine

News archive for The Department of Biomedicine

This phase IB/II trial is designed to investigate the safety and survival benefits for patients with recurrent glioblastoma with unmethylated MGMT promoter treated with Bortezomib and Temozolomide in a specific schedule.
For the third time, the Faculty of Medicine organized a career day for its PhD candidates. NTNU sent representatives to learn from us.
In an article published in Aftenposten Viten, researcher Marte Innselset Flydal describes how she is planning to develop medicine for children suffering from the rare disease phenylketonuria.
Researcher's Grand Prix-cadidate Illimar Hugo Rekand is working to keep us healthy. He is investigating new opportunities for making new medicines in a world where antibiotic resistance is an increasing challenge.
The fall semester at the Department of Biomedicine presents many exciting national and international lecturers.
The post-synaptic protein Arc has been termed a master regulator of memory. In line with its homology to certain viral proteins, it has also been shown recently to form virus-like capsids. We have elucidated for the first time the 3D structure of full-length monomeric Arc.
Thanks to funding from the Faculty of Medicine MIC recently got a new confocal in house. It was installed before summer and is ready to use.
A range of psychiatric disorders have molecular similarities that modern diagnostic tools don't recognize. This shows an international study with 2 million participants. The K.G. Jebsen center for neuropsychiatric disorders has provided Norwegian data and analyses.
Injection of a genetically modified polio virus into the brain can give brain cancer patients several years more than normal treatment.
Professor Jan Haavik, head of the Neurotargeting Research Group and KG Jebsen Center for Research on Neuropsychiatric Disorders, was recently elected as a member of the Norwegian Academy of Sciences and Letters.
Twelve students in the master class of 2018 at the Department of Biomedicine lower their shoulders after having submitted their master theses.
A research team led by James Lorens at the Department of Biomedicine and CCBIO used new technology to determine how breast tissue changes with age may contribute to breast cancer risk. The research is published in Cell Reports, with a commentary on Eureka Alert.
Aminur Rahman, PhD, has been awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award
Read a summary of how researchers from UiB investigate new genetic variants associated with intellectual disability, autism spectrum disorder, and congenital abnomalies.
Researchers at the University of Florence had been looking for an new anti-cancer drug, when they realized the old rat poison called Vacor could be the answer to their searches
These researchers have made a sensational finding in cell biology. Adrian Drazic, Henriette Aksnes and Michaël Marie from Thomas Arnesen's group found an enzyme that others have been looking for for 30 years.
Open for registration, deadline 23rd of February.
At the UiB, health minister Bent Høie met representatives of the health industry and health institutions to receive input for a new parliamentary report on the health industry.

Pages